Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients

被引：0
|
作者：
Tsuchiya, N
Satoh, S
Tada, H
Li, ZH
Ohyama, C
Sato, K
Suzuki, T
Kato, T
Habuchi, T
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)39048-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：490 / 491
页数：2
相关论文
共 50 条
  • [1] Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India
    Prasad, Narayan
    Jaiswal, Akhilesh
    Behera, Manas Ranjan
    Agarwal, Vikas
    Kushwaha, Ravi
    Bhadauria, Dharmendra
    Kaul, Anupama
    Gupta, Amit
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (01): : 28 - 38
  • [2] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [3] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [4] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [5] MDR1 AND CYP3A5 GENE POLYMORPHISMS AND IT'S RELATIONSHIP TO TACROLIMUS PHARMACOKINETICS IN MEXICAN RENAL TRANSPLANT CHILDREN.
    Garcia-Roca, Pilar
    Perdomo, Mayela
    Castaneda-Hernandez, Gilberto
    Reyes-Perez, Herlinda
    Maria Hernandez, Ana
    Fuentes, Yolanda
    Medeiros, Mara
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 57 - 57
  • [6] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [7] Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CMC19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
    Miura, Masatomo
    Inoue, Kazuyuki
    Kagaya, Hideaki
    Satoh, Shigeru
    Tada, Hitoshi
    Sagae, Yoshinori
    Habuchi, Tomonori
    Suzuki, Toshio
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (04) : 167 - 175
  • [8] Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tada, H
    Tsuchiya, N
    Satoh, S
    Kagaya, H
    Li, Z
    Sato, K
    Miura, M
    Suzuki, T
    Kato, T
    Habuchi, T
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1730 - 1732
  • [9] IMPACT OF CYP3A5, CYP3A4 AND MDR1 GENE POLYMORPHISMS ON TROUGH CONCENTRATIONS OF TACROLIMUS, CYCLOSPORINE AND SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Shi, Yunying
    Li, Yi
    Cai, Bei
    Cai, Bei
    Zou, Yuangao
    Tao, Ye
    Wang, Lanlan
    TRANSPLANT INTERNATIONAL, 2013, 26 : 84 - 84
  • [10] Impact of CYP3A5 and MDR1 polymorphisms on tacrolimus and sirolimus kinetics of kidney transplant recipients
    Frisman, M
    Renders, L
    Haenisch, S
    Mosyagin, I
    Cascorbi, I
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 705 - 706
12345